has also been launched in Europe and has realized similar clinical success as experienced in the United States.
These certifications assure patients, physicians and third party payors that SAFHS
adheres to world class quality standards.
It is Exogen's intent to maintain an aggressive intellectual property program on SAFHS
and all significant methods and patents.
All forward-looking statements involve risks and uncertainties, including, without limitation, risks associated with gaining acceptance by the medical community of the use of the SAFHS
device for the treatment of fresh fractures; obtaining adequate reimbursement from third party payors; commercializing the SAFHS
device to treat additional types of fractures; marketing the Company's products internationally; and other risks detailed in the Company's filings and reports with the Securities and Exchange Commission.
is recognized for its independent, quality technology assessments and we believe their revision of our rating is a powerful acknowledgment of the clinical support for SAFHS
and its potential to improve the health outcome for patients.
Currently S&N has 11 direct and 185 distributor and agent representatives who market SAFHS
in the United States.
Larry Papasan, President of Smith & Nephew's Orthopaedic Division said, "We're excited to partner with Exogen to market their SAFHS
McBrayer noted that during the third fiscal quarter, articles on SAFHS
low-intensity ultrasound fracture therapy appeared in four peer-reviewed journals: Spine, Medicine & Science in Sports & Exercise, Clinical Orthopaedics and Related Research and Surgical Technology International VII.
It has diligently taken SAFHS
through the import and reimbursement approval process while preparing the Japanese market through physician education and further research.
Plans are underway for a launch of SAFHS
2000 in Japan.
Exogen's Japanese partner, Teijin Limited, has received import approval for the first generation SAFHS
Model 2A and has applied for import approval of the SAFHS
therapy has been a subject at numerous scientific conferences in 1997, including the American Academy of Orthopaedic Surgeons' Science Writers' Conference.